Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.50
Bid: 129.00
Ask: 132.00
Change: 4.00 (3.16%)
Spread: 3.00 (2.326%)
Open: 127.50
High: 131.00
Low: 127.50
Prev. Close: 126.50
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and COVID-19 Update

14 May 2020 07:00

RNS Number : 8340M
Eurocell plc
14 May 2020
 

14 May 2020

 

EUROCELL PLC

(Symbol: ECEL)

 

AGM and COVID-19 Update

 

Eurocell, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following COVID-19 update ahead of its Annual General Meeting to be held at 3pm today.

 

Initial Actions in Response to COVID-19

As previously announced, performance in the 11 weeks to 20 March 2020 was in line with our expectations and there was no discernible impact on trading from COVID-19. Since then, our manufacturing plants, branch network, distribution and recycling operations have all been closed, in line with the official guidance from the UK Government.

 

Alongside the closure of our operations, we also took a number of significant, swift actions to conserve cash. These included the deferral of non-essential operating costs and the vast majority of planned capital expenditure whilst operations remained closed, and cancellation of the final dividend payment for the year ended 31 December 2019. Also as part of these actions, the Board and other members of the senior management team agreed to a 20% reduction in remuneration. In addition, we have continued to make use of various Government measures available, including the Coronavirus Job Retention Scheme.

 

Bank Facility and Share Placing

We have a strong balance sheet and were able to increase our bank facility to £75 million in March 2020. As previously disclosed, we continue to believe our banks will be supportive of reviewing covenants, if required.

 

Given the ongoing uncertainty of the COVID-19 situation, on 1 April we raised approximately £17.6m by way of a share placing. Net proceeds will be used to ensure we retain headroom on our bank facility, even under an extended shut-down, and to provide sufficient liquidity for investment in our new state-of-the-art warehouse. As well as being key to increasing total capacity, the new warehouse will deliver improved operational efficiencies. Good headroom on our bank facility will ensure the business is well placed to capitalise on opportunities when markets re-open.

 

Re-opening Plans

We are now pleased to announce that, following the latest guidance from the Government, which permits tradesmen to work in domestic dwellings so long as appropriate precautions are taken, we have implemented the first steps towards re-opening the business. On 11 May we recommenced supply to our fabricator customers from existing stocks and opened six branches around the country. This is allowing us to test our safe-working practices and begin to assess the level of customer demand.

 

We are encouraged that trading over the first three days has been robust, although it is not yet clear whether this is a result of pent up or underlying demand. Subject to the on-going results from these activities, and in particular there being sufficient underlying demand, we plan a phased re-opening of the business over the coming weeks. This includes a return to manufacturing when required to ensure continuity of supply to customers.

 

In the meantime, fit-out of the new warehouse remains on track and we continue to target being operational early in 2021, although this date may still be affected by COVID-19 developments.

 

We will provide a further update when there is more clarity on the impact of COVID-19 on the Group.

 

Annual General Meeting

The 2020 Annual General Meeting will be held at 3pm today at Fairbrook House, Clover Nook Road, Alfreton, Derbyshire, DE55 4RF. As previously announced, and in line with Government guidance in relation to COVID-19, shareholders, proxies and other attendees will not be permitted to attend the AGM in person and shareholders have been strongly advised to vote by proxy. A facility to ask the directors questions by email was made available. Answers will be published, in due course, on the Company's website: www.eurocell.co.uk.

 

~~~~~~~~~~~~~~~~~~~~~~~

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

Teneo

Ben Foster

+44 (0) 777 624 0806

 

Camilla Cunningham

+44 (0) 7464 982 426

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVXLFFBELFBBL
Date   Source Headline
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20244:30 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSInvestor Presentation
20th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSBlock listing Interim Review
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
23rd Jan 20247:00 amRNSYear End Trading Update
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.